TickerFactsScreenerDevelopers

SELLAS Life Sciences Group, Inc. (SLS) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2010: $5.05M2011: $20.86M2012: $27.23M2013: $82.09M2014: $43.43M2015: $68.63M2016: $11.42M2017: $31.46M2018: $11.67M2019: $10.52M2020: $18.09M2021: $5.93M2022: $16.09M2023: $14.20M2024: $9.97M2025: $7.47M$7.47M
2010Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$7.47M-25.0%
2024$9.97M-29.8%
2023$14.20M-11.8%
2022$16.09M+171.5%
2021$5.93M-67.2%
2020$18.09M+72.0%
2019$10.52M-9.9%
2018$11.67M-62.9%
2017$31.46M+175.5%
2016$11.42M-83.4%
2015$68.63M+58.0%
2014$43.43M-47.1%
2013$82.09M+201.5%
2012$27.23M+30.6%
2011$20.86M+313.3%
2010$5.05M—